EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway

Introduction and Objectives: To study the effect of eukaryotic initiation factor 3B (EIF3B) on the invasion and migration of hepatocellular carcinoma (HCC) and its potential mechanism. Materials and Methods: The clinical significance of EIF3B expression was studied with The Cancer Genome Atlas (TCGA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ling Wang, Chuanzhong Huang, Wansong Lin, Zhifeng Zhou, Jieyu Li, Mingshui Chen, Lingyu Zhang, Yunbin Ye
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Annals of Hepatology
Subjects:	Hepatocellular carcinoma EIF3B Invasion Metastasis TGFBI-MAPK-ERK
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124003478
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preliminary analysis of the diagnostic value and mechanism of action of TGFbI and S100A4 in hepatocellular carcinoma
by: Zhao Liang, et al.
Published: (2025-01-01)

Genetic epidemiology of epithelial-stromal TGFBI dystrophies in a large Korean population
by: Eun Hye Cho, et al.
Published: (2025-07-01)

L-741626 inhibits hepatocellular carcinoma progression by targeting Ref-1 to suppress MAPK/ERK signalling pathway activity
by: Shuiling Jin, et al.
Published: (2025-04-01)

Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors
by: Florian Selt, et al.
Published: (2025-04-01)

Hypoxic conditions affect transcriptome of endometrial stromal cells in endometriosis and promote TGFBI axis
by: Meruert Sarsenova, et al.
Published: (2024-12-01)

MiR‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK/ERK Signaling Pathway
by: Zhipeng Quan, et al.
Published: (2024-12-01)

MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01)

Integrated omics reveals the regulatory role of PKCα in Sertoli cell proliferation and apoptosis through the MAPK/ERK signaling pathway in goose testis
by: Yupu Song, et al.
Published: (2025-06-01)

ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
by: Mohamed I Saad, et al.
Published: (2019-03-01)

The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications
by: Hanlin Xu, et al.
Published: (2025-05-01)

Role of ERK1/2 and p38 Protein Kinases in Tumors: Biological Insights and Clinical Implications
by: Aleksandra Emelyanova, et al.
Published: (2025-05-01)

PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway
by: Chuanming Lin, et al.
Published: (2025-04-01)

Platelet-derived growth factor-B signalling might promote epithelial-mesenchymal transition in gastric carcinoma cells through activation of the MAPK/ERK pathway
by: Jiangyan Yin, et al.
Published: (2021-03-01)

YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway
by: Tai Tian, et al.
Published: (2024-12-01)

Exploreing the potential mechanism of Aitongxiao formula inhibiting hepatocellular carcinoma in vitro and in vivo based on network Pharmacology
by: Xiaoqing Zhao, et al.
Published: (2025-07-01)

Isomeric 3-Pyridinylmethylcoumarins Differ in Erk1/2-Inhibition and Modulation of BV2 Microglia-Mediated Neuroinflammation
by: Rami Schulzki, et al.
Published: (2025-06-01)

Protection of chickens from Mycoplasma gallisepticum through the MAPK/ERK/JNK pathway by a compound of ten Chinese medicine formulas
by: Tengfei Wang, et al.
Published: (2025-06-01)

Human eIF2A has a minimal role in translation initiation and in uORF-mediated translational control in HeLa cells
by: Mykola Roiuk, et al.
Published: (2025-07-01)

Natural products modulating MAPK for CRC treatment: a promising strategy
by: Lin Zhou, et al.
Published: (2025-03-01)

Effects of alpha-ketoisocaproate in oxidative stress-induced C2C12 myotubes via inhibition of p38 MAPK and ERK1/2
by: Pooreum Lim, et al.
Published: (2025-03-01)

TLR4 signalling protects Sertoli cells from cell stress via reprogramming inflammasome and autophagy pathways in MAPK1/ERK2 dependent way
by: Elina Avramska, et al.
Published: (2023-03-01)

High gestational leucine level dampens WDPCP/MAPK signaling to impair the EMT and migration of cardiac microvascular endothelial cells in congenital heart defects
by: Wei Hong, et al.
Published: (2024-10-01)

Transcription factor XBP1s promotes endometritis-induced epithelial-mesenchymal transition by targeting MAP3K2, a key gene in the MAPK/ERK pathway
by: Kangkang Gao, et al.
Published: (2025-02-01)

Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
by: Qiyuan Su, et al.
Published: (2024-12-01)

Pengaruh Sari Seduh Teh Hitam (Camellia sinensis) terhadap Ekspresi IGF-1, ERK1/2 dan PPARɣ pada Jalur MAPK (Mitogen Activated Protein Kinase) Jaringan Lemak Viseral Tikus Wistar dengan Diet Tinggi Lemak
by: Hendra Susanto, et al.
Published: (2012-12-01)

Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals
by: Junfei Zhu, et al.
Published: (2019-12-01)

BRAIN METASTASIS FROM HEPATOCELLULAR CARCINOMA: A RARE CASE
by: A. Kh. Bekyashev, et al.
Published: (2015-04-01)

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway
by: Jinhai Li, et al.
Published: (2025-06-01)

Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway
by: Yongfei He, et al.
Published: (2025-07-01)

Phthalates promote lenvatinib resistance in hepatocellular carcinoma through the HPX-MAPK pathway
by: Jinlu Han, et al.
Published: (2025-09-01)

Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer
by: Yu-Chin Liu, et al.
Published: (2025-01-01)

A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
by: Yue Fu, et al.
Published: (2025-07-01)

Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
by: Vid Mlakar, et al.
Published: (2024-12-01)

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
by: Liu Rui, et al.
Published: (2023-06-01)

NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway
by: Li Y, et al.
Published: (2025-05-01)

Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
by: Wu Xianjian, et al.
Published: (2025-08-01)

A case of resected hepatocellular carcinoma with gallbladder metastasis
by: Takaaki Hanazawa, et al.
Published: (2021-06-01)

FERMT1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by activating EGFR/AKT/β-catenin and EGFR/ERK pathways
by: Wubin Guo, et al.
Published: (2024-12-01)

Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway
by: Guannan Zhao, et al.
Published: (2025-01-01)

Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell Huh-7 by regulating apoptosis and metastases pathways
by: Jie Lin, et al.
Published: (2020-06-01)